Key result
Phenol dose-dependently stimulates adenylate cyclase and exerts biphasic effects on bTSH binding in thyroid membranes.
Why the study?
The ability of commercial hCG preparations and their additives to stimulate adenylate cyclase in human thyroid membranes was unclear.
Phenol acts as a potent stimulator of adenylate cyclase in human thyroid membranes, which explains the activity of certain pharmaceutical hCG preparations.
Answers are grounded in this paper and cite their sources.
Phenol in hCG preparations may artifactually stimulate thyroid activity in vitro; leaves open whether purified formulations are needed for clinical assays or use.
Among several commercial hCG preparations tested for their ability to stimulate adenylate cyclase in a human thyroid particulate fraction, only a pharmaceutical preparation (APL) was active. Activity of this preparation was lost during dialysis, but could be restored fully by the addition of phenol and partially by the addition of benzyl alcohol, the two additives present in APL. Phenol itself (0.040 - 2.0 mg/ml) induced a potent, dose-dependent stimulation of adenylate cyclase activity in a human thyroid particulate fraction and was also active in plasma membranes from rat liver and kidney cortex. Phenol exerted a biphasic effect on [125I]-bTSH binding to human thyroid membranes. Concentrations between 0.33 and 3.3 mg/ml were stimulatory to binding, while higher concentrations were inhibitory.
No takes yet. Share an insight, caveat, or question.
AMIR et al. (1981) studied this question. Phenol was evaluated on Adenylate cyclase activity and [125I]-bTSH binding. Phenol induced a potent, dose-dependent stimulation of adenylate cyclase activity in human thyroid membranes and exerted a biphasic effect on [125I]-bTSH binding.
Synapse has enriched 10 related papers. Consider them for comparative context: